0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Yu Shyr, PhD; Leora Horn, MD; Lynne Berry, PhD
JAMA Oncol. Published online March 19, 2015. doi:10.1001/jamaoncol.2015.0407

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Darius N. Lakdawalla, PhD; Jacquelyn W. Chou, MPP, MPL; Mark T. Linthicum, MPP; et al.
JAMA Oncol. Published online March 19, 2015. doi:10.1001/jamaoncol.2015.0203
Includes: Supplemental Content

JAMA | 
Viewpoint |  FREE ONLINE FIRST
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. Published online March 19, 2015. doi:10.1001/jama.2015.2571

JAMA | 
Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(11):1089-1091. doi:10.1001/jama.2015.0957.

JAMA Oncology | 
Viewpoint |  FREE ONLINE FIRST
Hugo M. Horlings, MD, PhD; Sohrab P. Shah, PhD; David G. Huntsman, MD
JAMA Oncol. Published online March 12, 2015. doi:10.1001/jamaoncol.2015.35

JAMA Oncology | 
JAMA Oncology Patient Page |  FREE ONLINE FIRST
Howard (Jack) West, MD
JAMA Oncol. Published online March 05, 2015. doi:10.1001/jamaoncol.2015.0137

JAMA Ophthalmology | 
Original Investigation |  ONLINE FIRST
Susan B. Bressler, MD; Talat Almukhtar, MBChB; Anjali Bhorade, MD; et al.
JAMA Ophthalmol. Published online February 26, 2015. doi:10.1001/jamaophthalmol.2015.186

JAMA | 
Editorial | 
Howard L. McLeod, PharmD
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086.

JAMA | 
Viewpoint | 
Jennifer A. Doudna, PhD
JAMA. 2015;313(8):791-792. doi:10.1001/jama.2015.287.

JAMA Oncology | 
Observation |  FREE ONLINE FIRST
Vivek Subbiah, MD; Pete Anderson, MD, PhD; Eric Rohren, MD, PhD
JAMA Oncol. Published online February 19, 2015. doi:10.1001/jamaoncol.2014.289

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA Oncology
Invited Commentary  | 
Are We Making Progress in Lung Cancer Using Progression-Free Survival as a Surrogate End Point?
Yu Shyr, PhD; Leora Horn, MD; Lynne Berry, PhD
JAMA Oncology
Original Investigation  | 
Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non–Small-Cell Lung Cancer
Darius N. Lakdawalla, PhD; Jacquelyn W. Chou, MPP, MPL; Mark T. Linthicum, MPP; et al.
JAMA
Medical News & Perspectives  | 
Precision Medicine: The Future or Simply Politics?
Rita Rubin, MA